Search

Your search keyword '"Jill N. Anderson"' showing total 10 results
Start Over Author "Jill N. Anderson" Publisher elsevier bv
10 results on '"Jill N. Anderson"'

4. CLINICAL TRIAL OUTCOMES IN REI AND OTHER GYNECOLOGY SUBSPECIALTIES: AN ANALYSIS OF EARLY DISCONTINUATION, RESULTS REPORTING AND PUBLICATION BETWEEN 2007-2020

Author

Christopher J. Magnani, Brannon T. Weeks, Alison Conway Fitzgerald, Shanique A. Martin, Anna Marie P Young, Naixin Zhang, Katelyn Chan, Tene Redman, Modupe Adetunji, Connie Lu, Zesemayat K. Mekonnen, Jill N. Anderson, Magdy P. Milad, Michael Richardson, Jecca R. Steinberg, and Brandon E. Turner

Subjects
Clinical trial, medicine.medical_specialty, Early discontinuation, Reproductive Medicine, business.industry, General surgery, Obstetrics and Gynecology, Medicine, business
Published
2021
Full Text
View/download PDF

5. The obstetrical research landscape: a cross-sectional analysis of clinical trials from 2007-2020

Author

Irogue Igbinosa, Jecca R. Steinberg, Wendy Y. Zhang, Brannon T. Weeks, Christopher J. Magnani, Michael Richardson, Jill N. Anderson, Brandon E. Turner, Yasser Y. El-Sayed, Anna I. Girsen, Alison Conway Fitzgerald, Deirdre J. Lyell, Katelyn Chan, Sarah E. Lindsay, and Griselda Reyes

Subjects
medicine.medical_specialty, Databases, Factual, Obstetric studies, Cross-sectional study, Obstetric investigations, Logistic regression, Maternal-Fetal Medicine, Odds Ratio, Obstetric morbidity, National Institutes of Health, medicine, Humans, Industry, Maternal health, Registries, Clinicaltrails.gov, Proportional hazards model, business.industry, Original Research: Obstetrics, Hazard ratio, General Medicine, United States, Confidence interval, Obstetrics, Clinical trial, Cross-Sectional Studies, Research funding, Clinical research, Obstetric complications, Emergency medicine, business
Abstract

Background Obstetric complications impact over a third of women globally, but are underrepresented in clinical research. Little is known about the comprehensive obstetric clinical trial landscape, how it compares to other fields, or factors associated with the successful completion of obstetric trials. Objectives To characterize obstetric clinical trials registered on ClinicalTrials.gov with the primary objective of identifying features associated with early discontinuation and results reporting. Study Design This is a cross-sectional study with descriptive, logistic regression and cox regression analyses of clinical trials registered on ClinicalTrials.gov. Our primary exposure variables were trial focus (obstetric or non-obstetric) and trial funding (industry, United States government or academic). We conducted additional exploratory analyses of other trial features including design, enrollment, and therapeutic focus. We examined the associations of exposure variables and other trial features with two primary outcomes: early discontinuation and results reporting. Results We downloaded data for all studies (n=332,417) registered on ClinicalTrials.gov from October 1, 2007 to March 9, 2020 from the Aggregate Analysis of the ClinicalTrials.gov database. We excluded studies with a non-interventional design (n=63,697) and those registered before October 1, 2007 (n=45,209). 4,276 (1.9%) obstetric trials (i.e. interventional studies), and 219,235 (98.1%) non-obstetric trials were compared. Among all trials, 2.8% of academic-funded trials, 1.9% of United States government-funded trials, and 0.4% of industry-funded trials focused on obstetrics. The quantity of obstetric trials increased over time (10.8% annual growth rate). Compared to non-obstetric trials, obstetric trials had a greater risk of early discontinuation (adjusted hazard ratio 1.40, 95% confidence interval: 1.21 to 1.62, p

Published
2021
Full Text
View/download PDF

6. 66: Early discontinuation and results reporting in obstetric clinical trials: An analysis of 3317 clinicaltrials.gov investigations

Author

Anna I. Girsen, Deirdre J. Lyell, Irogue Igbinosa, Griselda Reyes, Katelyn Chan, Jecca R. Steinberg, Yasser Y. El-Sayed, Alison A. Conway, Brannon T. Weeks, Brandon M. Turner, Jill N. Anderson, Wendy Y. Zhang, and Sarah E. Lindsay

Subjects
Clinical trial, medicine.medical_specialty, Early discontinuation, business.industry, Obstetrics and Gynecology, Medicine, business, Intensive care medicine
Published
2020
Full Text
View/download PDF

7. 725: The obstetric clinical trial landscape: a characterization of clinicaltrials.gov investigations from 2007-2018

Author

Anna I. Girsen, Alison A. Conway, Brannon T. Weeks, Deirdre J. Lyell, Jecca R. Steinberg, Brandon M. Turner, Irogue Igbinosa, Katelyn Chan, Wendy Y. Zhang, Yasser Y. El-Sayed, Jill N. Anderson, Griselda Reyes, and Sarah E. Lindsay

Subjects
Clinical trial, medicine.medical_specialty, business.industry, Obstetrics and Gynecology, Medicine, business, Intensive care medicine
Published
2020
Full Text
View/download PDF

8. 1040: Congenital diaphragmatic hernia-associated neonatal morbidity and mortality based on TOTAL trial severity designation

Author

Anna I. Girsen, Krisa P. Van Meurs, Yasser Y. El-Sayed, Yair J. Blumenfeld, Karl G. Sylvester, Susan R. Hintz, Jill N. Anderson, and Jaye C. Boissiere

Subjects
Neonatal morbidity, Pediatrics, medicine.medical_specialty, business.industry, Obstetrics and Gynecology, Medicine, Congenital diaphragmatic hernia, business, medicine.disease
Published
2019
Full Text
View/download PDF

10. 209: Obstetric and neonatal outcomes in pregnancies complicated by fetal lung masses: does final histology matter?

Author

Safwan Halabi, Richard A. Barth, Jill N. Anderson, Alexis S. Davis, Yair J. Blumenfeld, Yasser Y. El-Sayed, Susan R. Hintz, Karl G. Sylvester, Anna I. Girsen, and Matias Bruzoni

Subjects
medicine.medical_specialty, business.industry, Neonatal outcomes, Obstetrics, Obstetrics and Gynecology, Medicine, Histology, Fetal lung, business
Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results